Birju Mehta

CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma

Andras Heczey, Chrystal U. Louis, Barbara Savoldo et al. · Molecular Therapy · 2017 · 511 citations · Full text

Radiation Oncology, Cell Therapy, Cancer Immunosurveillance +6

Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma

Carlos A. Ramos, Natalie S. Grover, Anne Beaven et al. · Journal of Clinical Oncology · 2020 · 366 citations · Full text

In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin’s Lymphomas

Carlos A. Ramos, Rayne H. Rouce, Catherine Robertson et al. · Molecular Therapy · 2018 · 281 citations · Full text

Lymphocyte Development, T-regulatory Cell, Immunology +18

Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results

Andras Heczey, Xin Xu, Amy N. Courtney et al. · Nature Medicine · 2023 · 161 citations

Cell Therapy, Refractory Neuroblastoma, Medicine +7

Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma

Meenakshi Hegde, Sujith K. Joseph, Farzana Pashankar et al. · Nature Communications · 2020 · 158 citations · Full text